fluoxetine has been researched along with neuropeptide y in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (27.27) | 18.2507 |
| 2000's | 6 (27.27) | 29.6817 |
| 2010's | 8 (36.36) | 24.3611 |
| 2020's | 2 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Baker, RA; Brady, LS; Herkenham, M | 1 |
| Dryden, S; Frankish, HM; Pickavance, L; Wang, Q; Williams, G | 1 |
| Cochran, PK; Evans, VR; Hitchcock, JM; Nyquist-Battie, C; Unal, C | 1 |
| Curzon, G; Gibson, EL; Oluyomi, AO | 1 |
| Kask, A; Korrovits, P; Rägo, L; Schiöth, HB; Wikberg, JE | 1 |
| Caberlotto, L; Fuxe, K; Hurd, YL; Jimenez, P; Mathé, AA; Overstreet, DH | 1 |
| Bates, B; Fan, G; Fekete, C; Jaenisch, R; Kelly, J; Kuehn, R; Lechan, RM; Rios, M | 1 |
| Abecia, LC; Casis, L; Echevarría, E; Gutiérrez, A; Macarulla, MT; Portillo, MP; Rodríguez, VM; Saracíbar, G | 1 |
| Choi, SH; Jahng, JW; Kim, BT; Lee, SY; Myung, CS; Song, GY | 1 |
| Baker, GB; Dumont, Y; Fournier, A; Quirion, R; Redrobe, JP | 1 |
| Cameron, HA; Choe, JS; Crawley, JN; Heilig, M; Holmes, A; Karlsson, RM; Thorsell, A | 1 |
| Gehlert, DR; Hemrick-Luecke, SK; Shaw, J; Thompson, LK | 1 |
| Abumaria, N; Caberlotto, L; Domenici, E; Fuchs, E; Rygula, R; Zambello, E | 1 |
| Mennigen, JA; Moon, TW; Sassine, J; Trudeau, VL | 1 |
| Christiansen, SH; Olesen, MV; Woldbye, DP; Wörtwein, G | 1 |
| Crespi, F | 1 |
| Molina-Hernández, M; Téllez-Alcántara, NP | 1 |
| Álvaro, AR; Aveleira, C; Botelho, M; Cavadas, C; Pereira de Almeida, L; Sousa-Ferreira, L | 1 |
| Barros, Mda L; de Castro, RM; de Matos, RJ; de Souza, SL; Galindo, LC; Leandro, CG; Pinheiro, IL; Santana, RV | 1 |
| Braz, GRF; da Silva, AI; de Lima-Júnior, NC; Lagranha, CJ; Pedroza, AADS; Silva, SCA; Silva, TLA | 1 |
| Alam, MS; Ansari, MA; Ashraf, GM; Barkat, MA; Barreto, GE; Javed, MN; Nigar, S; Pottoo, FH; Sharma, S; Tabassum, N | 1 |
| Aquino, A; Brandão, LEM; Câmara, DA; Cavalcante, JS; Dierschnabel, AL; Engelberth, RC; Fiuza, FP; Lima, RH; Linhares, SSG; Meurer, YDSR | 1 |
1 review(s) available for fluoxetine and neuropeptide y
| Article | Year |
|---|---|
Appetite suppression by commonly used drugs depends on 5-HT receptors but not on 5-HT availability.
Topics: Appetite Depressants; Body Weight; Brain; Dopamine Agonists; Eating; Female; Fenfluramine; Fluoxetine; Humans; Male; Neuropeptide Y; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serotonin Agents | 1997 |
21 other study(ies) available for fluoxetine and neuropeptide y
| Article | Year |
|---|---|
Effects of long-term treatment with antidepressant drugs on proopiomelanocortin and neuropeptide Y mRNA expression in the hypothalamic arcuate nucleus of rats.
Topics: Adrenergic alpha-Antagonists; Animals; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Arcuate Nucleus of Hypothalamus; Fluoxetine; Gene Expression; Idazoxan; Image Processing, Computer-Assisted; Imipramine; In Situ Hybridization; Male; Neuropeptide Y; Phenelzine; Pro-Opiomelanocortin; Rats; Rats, Sprague-Dawley; RNA, Messenger; Time Factors | 1996 |
The serotonergic agent fluoxetine reduces neuropeptide Y levels and neuropeptide Y secretion in the hypothalamus of lean and obese rats.
Topics: Animals; Arcuate Nucleus of Hypothalamus; Autoradiography; Blood Glucose; Body Weight; Eating; Fluoxetine; Hormones; Hypothalamus; Male; Neural Pathways; Neurons; Neuropeptide Y; Obesity; Paraventricular Hypothalamic Nucleus; Rats; Rats, Wistar; Rats, Zucker; RNA, Messenger; Selective Serotonin Reuptake Inhibitors | 1996 |
Regulation of sympathetic presynaptic components in rat left ventricle during ligation of abdominal aorta.
Topics: Animals; Aorta, Abdominal; Binding Sites; Carrier Proteins; Fluoxetine; Hypertension; Ligation; Male; Methyltyrosines; Myocardium; Neuropeptide Y; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Presynaptic Terminals; Rats; Rats, Sprague-Dawley; Sympathetic Nervous System; Symporters; Time Factors; Ventricular Function, Left | 1996 |
Evidence that orexigenic effects of melanocortin 4 receptor antagonist HS014 are mediated by neuropeptide Y.
Topics: Animals; Eating; Feeding Behavior; Fluoxetine; Hypothalamus; Male; Neuropeptide Y; Peptides, Cyclic; Rats; Rats, Wistar; Receptor, Melanocortin, Type 4; Receptors, Corticotropin; Serotonin Antagonists; Signal Transduction | 1998 |
Alterations in neuropeptide Y levels and Y1 binding sites in the Flinders Sensitive Line rats, a genetic animal model of depression.
Topics: Amygdala; Animals; Antidepressive Agents, Second-Generation; Arcuate Nucleus of Hypothalamus; Brain Chemistry; Depression; Disease Models, Animal; Fluoxetine; Gastrointestinal Hormones; Hippocampus; Iodine Radioisotopes; Ligands; Neuropeptide Y; Occipital Lobe; Radioligand Assay; Rats; Rats, Mutant Strains; Rats, Sprague-Dawley; Receptors, Neuropeptide Y | 1999 |
Conditional deletion of brain-derived neurotrophic factor in the postnatal brain leads to obesity and hyperactivity.
Topics: Animals; Anxiety; Body Weight; Brain; Brain-Derived Neurotrophic Factor; Fasting; Fluoxetine; Gene Deletion; Gene Expression; Hyperglycemia; Hyperinsulinism; Hyperkinesis; Hypothalamus; Integrases; Leptin; Mice; Neuropeptide Y; Obesity; Pro-Opiomelanocortin; RNA, Messenger; Selective Serotonin Reuptake Inhibitors; Serotonin; Transfection; Viral Proteins | 2001 |
Effects of fluoxetine administration on neuropeptide y and orexins in obese zucker rat hypothalamus.
Topics: Adipocytes; Adipose Tissue; Animals; Blood Glucose; Body Composition; Body Weight; Carrier Proteins; Cell Size; Drinking; Eating; Fluoxetine; Hypothalamus; Immunoenzyme Techniques; Intracellular Signaling Peptides and Proteins; Leptin; Male; Neuropeptide Y; Neuropeptides; Obesity; Orexins; Organ Size; Oxygen Consumption; Rats; Rats, Zucker; Selective Serotonin Reuptake Inhibitors; Thyroid Hormones; Triglycerides | 2002 |
Role of neuropeptide Y and proopiomelanocortin in fluoxetine-induced anorexia.
Topics: Animals; Anorexia; Appetite Regulation; Arcuate Nucleus of Hypothalamus; Autoradiography; Body Weight; Brain Chemistry; Eating; Fluoxetine; Gene Expression Regulation; Male; Neuropeptide Y; Pro-Opiomelanocortin; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; RNA; RNA, Messenger; Selective Serotonin Reuptake Inhibitors | 2005 |
Role of serotonin (5-HT) in the antidepressant-like properties of neuropeptide Y (NPY) in the mouse forced swim test.
Topics: Animals; Antidepressive Agents; Disease Models, Animal; Fenclonine; Fluoxetine; Male; Mice; Motor Activity; Neuropeptide Y; Selective Serotonin Reuptake Inhibitors; Serotonin; Swimming | 2005 |
The neuropeptide Y Y1 receptor subtype is necessary for the anxiolytic-like effects of neuropeptide Y, but not the antidepressant-like effects of fluoxetine, in mice.
Topics: Animals; Antidepressive Agents, Second-Generation; Anxiety; Arousal; Cell Count; Cell Division; Conditioning, Classical; Depression; Fear; Female; Fluoxetine; Hippocampus; Injections, Intraventricular; Male; Maze Learning; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Knockout; Neurons; Neuropeptide Y; Receptors, Neuropeptide Y | 2008 |
Monoaminergic compensation in the neuropeptide Y deficient mouse brain.
Topics: Animals; Autoradiography; Biogenic Monoamines; Brain Chemistry; Chromatography, High Pressure Liquid; Citalopram; Fluoxetine; Immunohistochemistry; Male; Mice; Mice, Knockout; Neuropeptide Y; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins; Tyrosine 3-Monooxygenase | 2008 |
Chronic psychosocial stress alters NPY system: different effects in rat and tree shrew.
Topics: Analysis of Variance; Animals; Antidepressive Agents, Second-Generation; Disease Models, Animal; Fluoxetine; Gene Expression Regulation; Hippocampus; Hypothalamus; Male; Neuropeptide Y; Rats; Receptors, Neuropeptide Y; RNA, Messenger; Stress, Psychological; Time Factors; Tupaiidae | 2010 |
Waterborne fluoxetine disrupts feeding and energy metabolism in the goldfish Carassius auratus.
Topics: Animals; Behavior, Animal; Corticotropin-Releasing Hormone; Eating; Energy Metabolism; Feeding Behavior; Fluoxetine; Fructose-Bisphosphatase; Glucokinase; Glucose; Goldfish; Hexokinase; Liver; Neuropeptide Y; RNA, Messenger; Selective Serotonin Reuptake Inhibitors; Water Pollutants, Chemical; Weight Gain | 2010 |
Fluoxetine reverts chronic restraint stress-induced depression-like behaviour and increases neuropeptide Y and galanin expression in mice.
Topics: Amygdala; Animals; Brain; Dentate Gyrus; Depression; Fluoxetine; Galanin; Male; Mice; Neuropeptide Y; Parahippocampal Gyrus; Restraint, Physical; RNA, Messenger; Selective Serotonin Reuptake Inhibitors; Temporal Lobe | 2011 |
Influence of Neuropeptide Y and antidepressants upon cerebral monoamines involved in depression: an in vivo electrochemical study.
Topics: Amygdala; Animals; Anti-Anxiety Agents; Antidepressive Agents; Antidepressive Agents, Tricyclic; Anxiety; Arginine; Biogenic Monoamines; Biosensing Techniques; Brain Chemistry; Catecholamines; Depression; Electrochemistry; Fluoxetine; Imipramine; Indoles; Male; Neuropeptide Y; Neuropeptides; Oxidation-Reduction; Peptide Fragments; Rats; Rats, Wistar; Receptors, Neuropeptide Y; Selective Serotonin Reuptake Inhibitors | 2011 |
Fluoxetine, 17-β estradiol or folic acid combined with intra-lateral septal infusions of neuropeptide Y produced antidepressant-like actions in ovariectomized rats forced to swim.
Topics: Animals; Antidepressive Agents; Arginine; Behavior, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Estradiol; Female; Fluoxetine; Folic Acid; Injections, Intraventricular; Locomotion; Neuropeptide Y; Ovariectomy; Rats; Rats, Wistar; Receptors, G-Protein-Coupled; Receptors, Neuropeptide; Septal Nuclei; Swimming | 2011 |
Fluoxetine induces proliferation and inhibits differentiation of hypothalamic neuroprogenitor cells in vitro.
Topics: Animals; Antidepressive Agents, Second-Generation; Cell Differentiation; Cell Proliferation; Cells, Cultured; Female; Fluoxetine; Gene Expression; Humans; Hypothalamus; Nerve Tissue Proteins; Neural Stem Cells; Neuropeptide Y; Pregnancy; Pro-Opiomelanocortin; Rats; Serotonergic Neurons; Spheroids, Cellular | 2014 |
Neonatal serotonin reuptake inhibition reduces hypercaloric diet effects on fat mass and hypothalamic gene expression in adult rats.
Topics: Adipose Tissue; Age Factors; Animals; Animals, Newborn; Body Weight; Cholesterol; Diet; Eating; Female; Fluoxetine; Gene Expression Regulation, Developmental; Hypothalamus; Male; Neuropeptide Y; Pregnancy; Pro-Opiomelanocortin; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Serotonin; Triglycerides | 2015 |
Body composition, biochemical, behavioral and molecular alterations in overfed rats after chronic exposure to SSRI.
Topics: Animals; Behavior, Animal; Body Composition; Body Weight; Eating; Energy Metabolism; Fluoxetine; Hypothalamus; Male; Neuropeptide Y; Neuropeptides; Obesity; Rats; Rats, Wistar; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serotonin | 2019 |
Raloxifene potentiates the effect of fluoxetine against maximal electroshock induced seizures in mice.
Topics: Animals; Anticonvulsants; Bromocriptine; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Electroshock; Fluoxetine; Glutamic Acid; Hippocampus; Mice; Neuropeptide Y; Oxidative Stress; Raloxifene Hydrochloride; Receptors, Dopamine; Receptors, Serotonin; Seizures; Signal Transduction | 2020 |
Effects of prenatal exposure to fluoxetine on circadian rhythmicity in the locomotor activity and neuropeptide Y and 5-HT expression in male and female adult Wistar rats.
Topics: Animals; Antidepressive Agents; Circadian Rhythm; Female; Fluoxetine; Locomotion; Male; Neuropeptide Y; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Wistar; Serotonin | 2022 |